These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 20926450)

  • 1. Naturally occurring germline and tumor-associated mutations within the ATP-binding motifs of PTEN lead to oxidative damage of DNA associated with decreased nuclear p53.
    He X; Ni Y; Wang Y; Romigh T; Eng C
    Hum Mol Genet; 2011 Jan; 20(1):80-9. PubMed ID: 20926450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline and somatic cancer-associated mutations in the ATP-binding motifs of PTEN influence its subcellular localization and tumor suppressive function.
    Lobo GP; Waite KA; Planchon SM; Romigh T; Nassif NT; Eng C
    Hum Mol Genet; 2009 Aug; 18(15):2851-62. PubMed ID: 19457929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome.
    Bennett KL; Mester J; Eng C
    JAMA; 2010 Dec; 304(24):2724-31. PubMed ID: 21177507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of novel naturally occurring splice variants of PTEN and their functional consequences in Cowden syndrome and sporadic breast cancer.
    Agrawal S; Eng C
    Hum Mol Genet; 2006 Mar; 15(5):777-87. PubMed ID: 16436456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN autoregulates its expression by stabilization of p53 in a phosphatase-independent manner.
    Tang Y; Eng C
    Cancer Res; 2006 Jan; 66(2):736-42. PubMed ID: 16424003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN lipid phosphatase activity and proper subcellular localization are necessary and sufficient for down-regulating AKT phosphorylation in the nucleus in Cowden syndrome.
    He X; Saji M; Radhakrishnan D; Romigh T; Ngeow J; Yu Q; Wang Y; Ringel MD; Eng C
    J Clin Endocrinol Metab; 2012 Nov; 97(11):E2179-87. PubMed ID: 22962422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cowden syndrome-associated germline SDHD variants alter PTEN nuclear translocation through SRC-induced PTEN oxidation.
    Yu W; He X; Ni Y; Ngeow J; Eng C
    Hum Mol Genet; 2015 Jan; 24(1):142-53. PubMed ID: 25149476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN nuclear localization is regulated by oxidative stress and mediates p53-dependent tumor suppression.
    Chang CJ; Mulholland DJ; Valamehr B; Mosessian S; Sellers WR; Wu H
    Mol Cell Biol; 2008 May; 28(10):3281-9. PubMed ID: 18332125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tumor suppressor PTEN interacts with p53 in hereditary cancer (Review).
    Nakanishi A; Kitagishi Y; Ogura Y; Matsuda S
    Int J Oncol; 2014 Jun; 44(6):1813-9. PubMed ID: 24718924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cowden syndrome-affected patients with PTEN promoter mutations demonstrate abnormal protein translation.
    Teresi RE; Zbuk KM; Pezzolesi MG; Waite KA; Eng C
    Am J Hum Genet; 2007 Oct; 81(4):756-67. PubMed ID: 17847000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53.
    Ni Y; He X; Chen J; Moline J; Mester J; Orloff MS; Ringel MD; Eng C
    Hum Mol Genet; 2012 Jan; 21(2):300-10. PubMed ID: 21979946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP modulates PTEN subcellular localization in multiple cancer cell lines.
    Lobo GP; Waite KA; Planchon SM; Romigh T; Houghton JA; Eng C
    Hum Mol Genet; 2008 Sep; 17(18):2877-85. PubMed ID: 18579579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics and structural stability effects of germline PTEN mutations associated with cancer versus autism phenotypes.
    Smith IN; Thacker S; Jaini R; Eng C
    J Biomol Struct Dyn; 2019 Apr; 37(7):1766-1782. PubMed ID: 29663862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a Cowden syndrome patient with a novel PTEN mutation and establishment of patient-derived induced pluripotent stem cells.
    Obayashi F; Hamada A; Yamasaki S; Kanda T; Toratani S; Okamoto T
    In Vitro Cell Dev Biol Anim; 2022 Jan; 58(1):69-78. PubMed ID: 34984555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN phosphorylation and nuclear export mediate free fatty acid-induced oxidative stress.
    Wu Y; Zhou H; Wu K; Lee S; Li R; Liu X
    Antioxid Redox Signal; 2014 Mar; 20(9):1382-95. PubMed ID: 24063548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation-positive and mutation-negative patients with Cowden and Bannayan-Riley-Ruvalcaba syndromes associated with distinct 10q haplotypes.
    Pezzolesi MG; Li Y; Zhou XP; Pilarski R; Shen L; Eng C
    Am J Hum Genet; 2006 Nov; 79(5):923-34. PubMed ID: 17033968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cowden syndrome-associated germline succinate dehydrogenase complex subunit D (SDHD) variants cause PTEN-mediated down-regulation of autophagy in thyroid cancer cells.
    Yu W; Ni Y; Saji M; Ringel MD; Jaini R; Eng C
    Hum Mol Genet; 2017 Apr; 26(7):1365-1375. PubMed ID: 28164237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 down-regulates phosphatase and tensin homologue deleted on chromosome 10 protein stability partially through caspase-mediated degradation in cells with proteasome dysfunction.
    Tang Y; Eng C
    Cancer Res; 2006 Jun; 66(12):6139-48. PubMed ID: 16778187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
    Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
    Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTEN expression in U251 glioma cells enhances their sensitivity to ionizing radiation by suppressing DNA repair capacity.
    Li HL; Wang CY; Fu J; Yang XJ; Sun Y; Shao YH; Zhang LH; Yang XM; Zhang XL; Lin J
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10453-10458. PubMed ID: 31841199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.